{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:45:20Z","timestamp":1785811520504,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Medical University Undergraduate Innovation and Entrepreneurship Training Program","award":["202410598008"],"award-info":[{"award-number":["202410598008"]}]},{"name":"the Clinical Research Climbing Project of The First Affiliated Hospital of Guangxi Medical University","award":["No.YYZS2020024"],"award-info":[{"award-number":["No.YYZS2020024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04966-4","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:34:43Z","timestamp":1780306483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combining preoperative clinical and ultrasound radiomic features to predict the predominant component of combined hepatocellular carcinoma-cholangiocarcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuanping","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinshu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuquan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"4966_CR1","doi-asserted-by":"crossref","unstructured":"Zhang Y-Z, Liu Y-C, Su T, Shi J-N, Huang Y, Liang B. Current advances and future directions in combined hepatocellular and cholangiocarcinoma. Gastroenterol Rep (Oxf). 2024;12:goae031.","DOI":"10.1093\/gastro\/goae031"},{"key":"4966_CR2","doi-asserted-by":"crossref","unstructured":"He C, Mao Y, Wang J, Song Y, Huang X, Lin X, et al. The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study. J Gastrointest Surg. 2018;22(7):1239\u201350.","DOI":"10.1007\/s11605-018-3756-3"},{"key":"4966_CR3","doi-asserted-by":"crossref","unstructured":"Huang S-S, Zuo M-X, Xie C-M. Combining Preoperative Clinical and Imaging Characteristics to Predict MVI in Hepatitis B Virus-Related Combined Hepatocellular Carcinoma and Cholangiocarcinoma. J Pers Med. 2023;13(2).","DOI":"10.3390\/jpm13020246"},{"key":"4966_CR4","doi-asserted-by":"crossref","unstructured":"Chi C-T, Chau G-Y, Lee R-C, Chen Y-Y, Lei H-J, Hou M-C, et al. Radiological features and outcomes of\u00a0combined hepatocellular-cholangiocarcinoma in\u00a0patients undergoing\u00a0surgical resection. J Formos Med Assoc. 2019;119(1 Pt 1):125\u201333.","DOI":"10.1016\/j.jfma.2019.02.012"},{"key":"4966_CR5","doi-asserted-by":"crossref","unstructured":"Ramai D, Ofosu A, Lai JK, Reddy M, Adler DG. Combined Hepatocellular Cholangiocarcinoma: A Population-Based Retrospective Study. Am J Gastroenterol. 2019;114(9):1496\u2013501.","DOI":"10.14309\/ajg.0000000000000326"},{"key":"4966_CR6","doi-asserted-by":"crossref","unstructured":"Kassahun WT, Hauss J. Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract. 2008;62(8):1271\u20138.","DOI":"10.1111\/j.1742-1241.2007.01694.x"},{"key":"4966_CR7","doi-asserted-by":"crossref","unstructured":"Sheng R, Yang C, Zhang Y, Wang H, Zheng B, Han J, et al. The significance of the predominant component in combined hepatocellular-cholangiocarcinoma: MRI manifestation and prognostic value. Radiol Med. 2023;128(9):1047\u201360.","DOI":"10.1007\/s11547-023-01682-x"},{"key":"4966_CR8","doi-asserted-by":"crossref","unstructured":"Xiao Y, Zheng X, Zhou C, Huang P, Wu F, Yang C, et al. Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction. Eur Radiol. 2022;33(2):1412\u201321.","DOI":"10.1007\/s00330-022-09131-5"},{"key":"4966_CR9","doi-asserted-by":"crossref","unstructured":"Aishima S, Kuroda Y, Asayama Y, Taguchi K, Nishihara Y, Taketomi A, et al. Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma. Hum Pathol. 2006;37(3):283\u201391.","DOI":"10.1016\/j.humpath.2005.08.019"},{"key":"4966_CR10","doi-asserted-by":"crossref","unstructured":"Park SH, Lee SS, Yu E, Kang HJ, Park Y, Kim SY, et al. Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis. J Magn Reson Imaging. 2016;46(1):267\u201380.","DOI":"10.1002\/jmri.25568"},{"key":"4966_CR11","doi-asserted-by":"crossref","unstructured":"Gentile D, Donadon M, Lleo A, Aghemo A, Roncalli M, di Tommaso L, et al. Surgical Treatment of Hepatocholangiocarcinoma: A Systematic Review. Liver Cancer. 2020;9(1):15\u201327.","DOI":"10.1159\/000503719"},{"key":"4966_CR12","doi-asserted-by":"crossref","unstructured":"Xiao Y, Huang P, Zhang Y, Lu X, Zhou C, Wu F, et al. Component prediction in combined hepatocellular carcinoma-cholangiocarcinoma: habitat imaging and its biologic underpinnings. Abdom Radiol (NY). 2024;49(4):1063\u201373.","DOI":"10.1007\/s00261-023-04174-8"},{"key":"4966_CR13","doi-asserted-by":"crossref","unstructured":"Huisman M, Akinci D'Antonoli T. What a Radiologist Needs to Know About Radiomics, Standardization, and Reproducibility. Radiology. 2024;310(2):e232459.","DOI":"10.1148\/radiol.232459"},{"key":"4966_CR14","doi-asserted-by":"crossref","unstructured":"Zhang J, Dong W, Li Y, Fu J, Jia N. Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data. Eur J Radiol. 2023;163:110839.","DOI":"10.1016\/j.ejrad.2023.110839"},{"key":"4966_CR15","doi-asserted-by":"crossref","unstructured":"Wang X, Wang W, Ma X, Lu X, Li S, Zeng M, et al. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance? Eur Radiol. 2020;30(10):5337\u201347.","DOI":"10.1007\/s00330-020-06861-2"},{"key":"4966_CR16","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhou C-W, Zhu G-Q, Li N, Qian X-L, Chong H-H, et al. A multidimensional nomogram combining imaging features and clinical factors to predict the invasiveness and metastasis of combined hepatocellular cholangiocarcinoma. Ann Transl Med. 2021;9(20):1518.","DOI":"10.21037\/atm-21-2500"},{"key":"4966_CR17","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-P\u00e9rez R, Bajorath J. Interpretation of Compound Activity Predictions from Complex Machine Learning Models Using Local Approximations and Shapley Values. J Med Chem. 2019;63(16):8761\u201377.","DOI":"10.1021\/acs.jmedchem.9b01101"},{"key":"4966_CR18","doi-asserted-by":"crossref","unstructured":"Zhou C, Lu X, Wang Y, Qian X, Yang C, Zeng M. Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma. Eur Radiol. 2022;32(10):6702\u201311.","DOI":"10.1007\/s00330-022-09065-y"},{"key":"4966_CR19","doi-asserted-by":"crossref","unstructured":"Chen Y, Lu Q, Zhu Y, Huang B, Dong Y, Wang W. Prediction of Microvascular Invasion in Combined Hepatocellular-Cholangiocarcinoma Based on Pre-operative Clinical Data and Contrast-Enhanced Ultrasound Characteristics. Ultrasound Med Biol. 2022;48(7):1190\u2013201.","DOI":"10.1016\/j.ultrasmedbio.2022.02.014"},{"key":"4966_CR20","doi-asserted-by":"crossref","unstructured":"Tian H, Chen Y, Zhao L, Liao C, Li S, Zhang B. Clinicopathologic and ultrasonographic features of combined hepatocellular-cholangiocarcinoma and its correlation with microvascular invasion: a predictive role of contrast-enhanced ultrasound. Front Oncol. 2024;14:1474675.","DOI":"10.3389\/fonc.2024.1474675"},{"key":"4966_CR21","doi-asserted-by":"crossref","unstructured":"Xia F, Zhang Q, Ndhlovu E, Zheng J, Gao H, Xia G. A nomogram for preoperative prediction of microvascular invasion in ruptured hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2023;35(5):591\u20139.","DOI":"10.1097\/MEG.0000000000002535"},{"key":"4966_CR22","doi-asserted-by":"crossref","unstructured":"Mao S, Yu X, Yang Y, Shan Y, Mugaanyi J, Wu S, et al. Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma. Sci Rep. 2021;11(1):13999.","DOI":"10.1038\/s41598-021-93528-7"},{"key":"4966_CR23","doi-asserted-by":"crossref","unstructured":"Miao G, Qian X, Zhang Y, Hou K, Wang F, Xuan H, et al. An MRI-Based Radiomics Model for Preoperative Prediction of Microvascular Invasion and Outcome in Intrahepatic Cholangiocarcinoma. Eur J Radiol. 2024;183:111896.","DOI":"10.1016\/j.ejrad.2024.111896"},{"key":"4966_CR24","doi-asserted-by":"crossref","unstructured":"Tang Z, Liu W-R, Zhou P-Y, Ding Z-B, Jiang X-F, Wang H, et al. Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma. J Cancer. 2019;10(22):5575\u201384.","DOI":"10.7150\/jca.32199"},{"key":"4966_CR25","doi-asserted-by":"crossref","unstructured":"Yen C-C, Yen C-J, Shan Y-S, Lin Y-J, Liu IT, Huang H-Y, et al. Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification. Histopathology. 2021;79(4):556\u201372.","DOI":"10.1111\/his.14384"},{"key":"4966_CR26","doi-asserted-by":"crossref","unstructured":"Wang Y, Yang Q, Li S, Luo R, Mao S, Shen J. Imaging features of combined hepatocellular and cholangiocarcinoma compared with those of hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in a Chinese population. Clin Radiol. 2019;74(5).","DOI":"10.1016\/j.crad.2019.01.016"},{"key":"4966_CR27","doi-asserted-by":"crossref","unstructured":"Li R, Yang D, Tang C-L, Cai P, Ma K-S, Ding S-Y, et al. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography. BMC Cancer. 2016;16:158.","DOI":"10.1186\/s12885-016-2156-x"},{"key":"4966_CR28","doi-asserted-by":"crossref","unstructured":"Hu F, Zhang Y, Li M, Liu C, Zhang H, Li X, et al. Preoperative Prediction of Microvascular Invasion Risk Grades in Hepatocellular Carcinoma Based on Tumor and Peritumor Dual-Region Radiomics Signatures. Front Oncol. 2022;12:853336.","DOI":"10.3389\/fonc.2022.853336"},{"key":"4966_CR29","doi-asserted-by":"crossref","unstructured":"Feng S-T, Jia Y, Liao B, Huang B, Zhou Q, Li X, et al. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI. Eur Radiol. 2019;29(9):4648\u201359.","DOI":"10.1007\/s00330-018-5935-8"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04966-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:07:50Z","timestamp":1785809270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04966-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4966"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04966-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University and conducted in accordance with the Declaration of Helsinki. The requirement of informed consent was waived by the Ethics Committee of First Affiliated Hospital of Guangxi Medical University owing to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"485"}}